John Cullity
Voorzitter bij HaemaLogiX Pty Ltd.
Vermogen: 7 M $ op 30-04-2024
Actieve functies van John Cullity
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Biosynergy Partners LLC | Corporate Officer/Principal | 01-09-2013 | - |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Directeur/Bestuurslid | 01-09-2016 | - |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015. | Voorzitter | - | - |
Directeur/Bestuurslid | 01-01-2015 | - | |
The Royal College of Physicians | Corporate Officer/Principal | - | - |
Loopbaan van John Cullity
Eerdere bekende functies van John Cullity
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
RACE ONCOLOGY LIMITED | Directeur/Bestuurslid | 20-04-2023 | 22-08-2023 |
Voorzitter | 06-03-2020 | 20-04-2023 | |
Ceramedix Holdings LLC | Directeur/Bestuurslid | 01-07-2015 | 01-03-2020 |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-01-2010 | 01-01-2017 |
Sanofi-Aventis Healthcare Pty Ltd. | Corporate Officer/Principal | - | - |
Merk Sharp & Dohme (Holdings) Pty Ltd.
Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Merk Sharp & Dohme (Holdings) Pty Ltd. develops, manufactures and markets drug therapies. The company was founded in 1958 and is headquartered in Macquarie Park, Australia. | Corporate Officer/Principal | - | - |
░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van John Cullity
London School of Economics & Political Science | Graduate Degree |
The University of Western Australia | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 7 |
Australië | 6 |
Verenigd Koninkrijk | 3 |
Operationeel
Corporate Officer/Principal | 6 |
Director/Board Member | 4 |
Chairman | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 5 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
RACE ONCOLOGY LIMITED | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Sanofi-Synthelabo, Inc. | Health Technology |
Merk Sharp & Dohme (Holdings) Pty Ltd.
Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Merk Sharp & Dohme (Holdings) Pty Ltd. develops, manufactures and markets drug therapies. The company was founded in 1958 and is headquartered in Macquarie Park, Australia. | Health Technology |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Sanofi-Aventis Healthcare Pty Ltd. | |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Health Technology |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015. | Health Technology |
Biosynergy Partners LLC | |
Ceramedix Holdings LLC |
- Beurs
- Insiders
- John Cullity
- Ervaring